Equally contributing first authors.
Copeptin and risk stratification in patients with ischemic stroke and transient ischemic attack: The CoRisk Study
Article first published online: 15 FEB 2012
© 2012 The Authors. International Journal of Stroke © 2012 World Stroke Organization
International Journal of Stroke
Volume 8, Issue 3, pages 214–218, April 2013
How to Cite
De Marchis, G. M., Katan, M., Weck, A., Brekenfeld, C., Mattle, H. P., Buhl, D., Müller, B., Christ-Crain, M. and Arnold, M. (2013), Copeptin and risk stratification in patients with ischemic stroke and transient ischemic attack: The CoRisk Study. International Journal of Stroke, 8: 214–218. doi: 10.1111/j.1747-4949.2011.00762.x
This study is registered in ClinicalTrials.gov under the number NCT00878813.
Conflict of interest: MK, MCC, BM, and PS received support from Thermo Fisher Scientific to attend meetings and fulfilled speaking engagements not related to the CoRisk study. BM serves as a consultant and receives research support from Thermo Fisher Scientific not related o this study. All other authors have no financial disclosure related to the present manuscript.
Funding: The study was supported by an unrestricted research grant of: B•R•A•H•M•S Biomarkers Clinical Diagnostics Division, Thermo Fisher Scientific, Neuendorfstr. 25;16761 Hennigsdorf-Berlin Germany; Foundation of the Inselspital Bern (Switzerland); Foundation Scientia et Arte, Bern (Switzerland); De Quervain's Grant for young clinical investigators, Clinical Trials Unit, Bern (Switzerland) to GMDM. Career Development Grant from the Swiss National Science Foundation (SNF) to MK. All supporting entities will have no role in the collection, management, analysis, and interpretation of the data; or the preparation, or approval of the manuscript.
- Issue published online: 15 MAR 2013
- Article first published online: 15 FEB 2012
- Foundation of the Inselspital Bern (Switzerland)
- Foundation Scientia et Arte, Bern (Switzerland)
- Clinical Trials Unit, Bern (Switzerland)
- Swiss National Science Foundation (SNF)
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
If your institution is a registered Wiley Online Library customer, you can log in under your institution's name to see our content. This access is provided by Shibboleth or Athens.
Type your institution's name in the box below. If your institution is a Wiley customer, it will appear in the list of suggested institutions.
Please note that there are currently a number of duplicate entries in the list of institutions. We are actively working on fixing this issue and apologize for any inconvenience caused.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.